$RYTM news
The latest RYTM stock news: headlines, filings, AI summaries and sentiment for $RYTM, updated around the clock.
- Rhythm Pharmaceuticals Shares Rise Following Reports of Potential Second Bidder
- Rhythm Pharmaceuticals Shares Surge Following Report of AstraZeneca Acquisition Bid
- Rhythm Pharmaceuticals Reports Q3 2026 Revenue Growth Driven by Acquired Hypothalamic Obesity Treatments
- RHYTHM PHARMACEUTICALS, INC. - 10-Q Filing
- Rhythm Pharmaceuticals Announces Q3 Revenue Growth and Phase III Trial Timeline for Bivamelagon
- RHYTHM PHARMACEUTICALS, INC. - 8-K Filing
- Stanley Druckenmiller's Duquesne Family Office Increases Healthcare Stock Holdings
- Rhythm Pharmaceuticals Shares Preliminary Positive Results from Phase 2 Trial for Prader-Willi Syndrome Treatment
- Rhythm (RYTM) Q1 2026 Earnings Call Summary
- Rhythm Pharmaceuticals Shares Rise on Strong Q1 Earnings and FDA Approval